Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer
NCT ID: NCT07044791
Last Updated: 2025-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
120 participants
INTERVENTIONAL
2018-02-02
2026-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer
NCT07077018
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
NCT00019643
PrefeRences And ChemoTherapy In Breast Cancer patiEnts
NCT06332976
Metformin and Nightly Fasting in Women With Early Breast Cancer
NCT05023967
Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens
NCT00149214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ARM A: Visits will be set up monthly in order to assess body weight, waist circumference, diet compliance (etc...) for all period of the BC adjuvant treatment (6 months).
ARM B: Visits will be set up only at the baseline, after 6 months namely at the end.
No drug treatment will be given to patients during the trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ARM A: intensive nutritional intervention
ARM A: Visits will be set up monthly in order to assess body weight, waist circumference, diet compliance (etc...) for all period of the BC adjuvant treatment (6 months).
Nutritional counseling. No drug treatment will be administered in this study.
Nutritional counseling. No drug treatment will be administered in this study.
ARM B: standard nutritional intervention
ARM B: Visits will be set up only at the baseline, after 6 months namely at the end
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutritional counseling. No drug treatment will be administered in this study.
Nutritional counseling. No drug treatment will be administered in this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \< 30 kg/m2
* Caucasians
* Histological diagnosis of invasive breast cancer
* Starting an adjuvant systemic treatment for breast cancer
* Available past medical history
* Informed consent to participate to the study
Exclusion Criteria
* BMI \>30 kg/m2
* Presence of a serious medical condition that could alter food absorption or prognosis
* Refusal to provide informed consent to participate in the study
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Grazia Arpino
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
A.O.U Federico II
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form: English version
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
280/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.